Absci Corporation

NASDAQ:ABSI

Biotechnology

Healthcare
$8.18 +1.04%

+$0.08 today

Market cap
$1.41B
Beta
2.46
P/E (TTM)
-9.4
EPS (TTM)
-$0.77
52W Low $2.24High $8.17

Volume 5.66M

Average 5.10M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$92.92M

FY 2025 · Annual

Investing Cash Flow

-$50.16M

FY 2025 · Annual

Financing Cash Flow

$105.95M

FY 2025 · Annual

+28.4% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(100.96M)(104.9M)(110.57M)(103.11M)(115.18M)
Depreciation & Amortization6.65M13.1M14M13.39M11.74M
Deferred Income Tax(8.9M)(505K)(52K)00
Stock-Based Compensation10.61M12.54M11.42M19.45M18.32M
Change in Working Capital(3.15M)(1.54M)1.52M(368K)423K
Accounts Receivables230K(148K)(666K)2.24M0
Inventory00000
Accounts Payables1.57M(533K)(786K)2.03M1.09M
Other Working Capital(4.95M)(859K)2.97M(4.63M)(671K)
Other Non-Cash Items35.15M(30K)19.05M(1.77M)(8.23M)
Operating Cash Flow(60.6M)(81.34M)(64.64M)(72.4M)(92.93M)
Capital Expenditures(38.05M)(16.18M)(860K)(404K)(1.11M)
Acquisitions (Net)(28.13M)(8M)001.31M
Purchases of Investments(1.2M)(108.59M)(147.35M)(186.11M)(119.87M)
Sales of Investments05M229.9M144M69.5M
Other Investing Activities0783K254K939K0
Investing Cash Flow(67.38M)(126.98M)81.94M(41.58M)(50.16M)
Debt Repayment120.85M4.58M(5.35M)(4.03M)(3.2M)
Common Stock Issued210.4M656K862K86.56M109.15M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00000
Financing Cash Flow336.19M5.24M(4.48M)82.53M105.95M
Effect of Forex Changes00000
Net Change in Cash208.22M(203.08M)12.83M(31.45M)(37.14M)
Free Cash Flow(98.65M)(97.51M)(65.5M)(72.81M)(94.03M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$115.2M
+ D&A$11.7M
+ Stock-Based Comp$18.3M
+ Deferred Tax$0
+ Working Capital$423.0K
- Other Non-Cash-$8.2M
= Operating Cash Flow-$92.9M
- Capex-$1.1M
= Free Cash Flow-$94.0M

Analysis

FY2025 free cash flow is -$94.0M. FCF conversion is 81.6% of net income. Operating cash flow was -$92.9M, with capex of -$1.1M. The largest bridge item is Stock-Based Comp at $18.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
S-3ASRS-3ASR filingNov 12, 2026
4Statement of changes in beneficial ownershipOct 30, 2026

Does ABSI generate free cash flow?

Absci Corporation (ABSI) generated -$94.03M of free cash flow in fiscal 2025.

How much operating cash flow does ABSI produce?

Operating cash flow was -$92.92M, before capital expenditures of $1.11M.